Lumexa Imaging Forms Joint Venture with World-Leading HSS to Expand New York Outpatient Imaging
LMRI is trading near its 52-week low of $6.45 (14% above the low).
Summary
Lumexa Imaging announced a joint venture with Hospital for Special Surgery (HSS) to expand advanced outpatient imaging services in the New York City metro area. This strategic partnership, Lumexa's ninth joint venture, significantly strengthens its presence in one of the nation's largest healthcare markets. The collaboration with HSS, a world leader in musculoskeletal health, aligns with Lumexa's growth strategy and builds on its recent swing to profitability in Q1 2026.
At the time of this announcement, LMRI was trading at $7.35 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $706.2M. The 52-week trading range was $6.45 to $19.45. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.